Valneva SARS-CoV-2 vaccine candidate (inactivated, adjuvanted)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Valneva SARS-CoV-2 vaccine candidate (inactivated, adjuvanted), covering 2022-03-24 to 2022-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects [Phase 1, Phase 2]